Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

426559

	registered interest
	date	05/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to improve children and young people's mental health services.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	15092
	answer	answer is ministerial correction date of answer 12/11/2015 answer text <p>Children and young people’s mental health is a priority area for this Government. We are committed to delivering the vision set out in <em>Future in mind</em> through the launch of a major system-wide transformation programme working alongside our partners in Government and arm’s length bodies. This will improve access and make services more widely available across the country.</p><br /><p>To support this transformation, an additional£1.4 billion funding has been made available over the course of this Parliament for spending on children and young people’s mental health, of which we are spending £173 million this year, including £30 million on eating disorders. This will be used to improve community-based services so that young people are helped earlier and are less likely to need to go into hospital. It will also enable the expansion and extension of the Children and Young People’s Improving Access to Psychological Therapies programme so that a wider range of those who need it are able to access high quality and evidence-based interventions wherever they may live. All clinical commissioning groups have been asked to work with their partners to develop Local Transformation Plans to transform their local offer to improve children and young people’s mental health and wellbeing.</p><br /><p>A national programme of work will support local areas, including the extension and expansion of the use of evidence- based interventions, tackling stigma, improving data and information to inform greater transparency and accountability and developing a specialist and stronger workforce.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 12/11/2015 10:03:31 answering member 1201 label Biography information for Alistair Burt
	tabling member	3960 label Biography information for Henry Smith

451413

	registered interest
	date	03/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the quantity and quality of specialist therapeutic support available to children who have experienced abuse.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	903553
	answer	answer is ministerial correction date of answer 09/02/2016 answer text <p>Children who have been abused may require a range of services to meet their needs. Local commissioners are responsible for assessing local need and ensuring the delivery of appropriate services. Local partners and NHS England need to work together to help children who have experienced abuse or neglect access appropriate care pathways and evidence-based care.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 09/02/2016 15:03:25 answering member 1201 label Biography information for Alistair Burt
	tabling member	3960 label Biography information for Henry Smith

671782

	registered interest
	date	11/01/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to NHS England's announcement on 6 December 2016 of an additional £200 million to improve local cancer services, what plans he has to ensure that that money will be used to roll out the Recovery Package and stratified pathways of follow-up care as costed in the Independent Cancer Taskforce report.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	59671
	answer	answer is ministerial correction date of answer 19/01/2017 answer text <p>The £200 million fund NHS England announced in December 2016 will be available to Cancer Alliances over the next two years to specifically support the areas the Cancer Taskforce strategy estimated would need additional investment including implementing the Recovery Package and rolling out stratified follow up pathways.</p><p> </p><p>Initial bids for funding are due on 18 January 2017. Clear guidance has been published and a regional and national panel will assess all bids received. The funding will be signed off by the NHS England Investment Committee.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 19/01/2017 11:56:42 answering member 4080 label Biography information for David Mowat
	tabling member	3960 label Biography information for Henry Smith

720556

	registered interest
	date	13/04/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he expects the recently established cancer delivery plans to be published.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	70573
	answer	answer is ministerial correction date of answer 25/04/2017 answer text <p>Currently there is no co-ordinated date for publication of cancer delivery plans.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 25/04/2017 15:32:03 answering member 4080 label Biography information for David Mowat
	tabling member	3960 label Biography information for Henry Smith

155948

	registered interest
	date	17/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to encourage flexibility in the licensing process for potential new treatments for rare conditions.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	214491
	answer	answer is ministerial correction date of answer 24/11/2014 answer text <p>Most new medicines for rare conditions are licensed by the European Commission.</p><p> </p><p>The European Union offers a range of incentives to encourage the development of these medicines in order to address unmet clinical need. These incentives include a period of 10 years market exclusivity, the provision of Protocol Assistance (scientific advice specifically tailored for orphan medicinal products) and fee reductions and waivers for regulatory procedures.</p><p> </p><p> </p><p> </p><p>Through the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom takes an active role in the decision making process at the European Medicines Agency’s Committee on Orphan Medicinal Products, ensuring applications for Orphan Drug designation of potential drug candidates for rare diseases are appropriately recognised, encouraging companies to develop their products further and recommending use of existing flexibilities such as conditional authorisation, authorisation under exceptional circumstances and accelerated assessment. The UK is actively involved in the European Medicines Agency’s adaptive licensing pilot that is exploring further use of these flexibilities. The MHRA has an Innovation Office that can offer advice and assistance to developers of drugs for rare diseases, including on the use of flexibilities.</p><p> </p><p><strong> </strong></p><p> </p><p>In addition, in the UK, the Early Access to Medicines Scheme aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.</p><p> </p><p> </p><p> </p><p>We are also commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 24/11/2014 17:23:13 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

155953

	registered interest
	date	17/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will set targets and goals for speeding up the use of off-patent drugs outside their licensed indications, where evidence supports that use.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	214424
	answer	answer is ministerial correction date of answer 24/11/2014 answer text <p>We have no plans to set such targets or goals.</p><p> </p><p> </p><p> </p><p>Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed ‘off-label’ outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.</p><p> </p><p> </p><p> </p><p>We are in the process of setting up a round-table discussion with key stakeholders, including NHS England and the National Institute for Health and Care Excellence to explore opportunities for supporting appropriate use of off-label drugs outside their licensed indications where the evidence supports this.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 24/11/2014 17:35:43 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

174759

	registered interest
	date	20/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Bile Duct Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what research his Department has commissioned into cholangiocarcinoma.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	221396
	answer	answer is ministerial correction date of answer 27/01/2015 answer text <p>The Department has not commissioned any research relating specifically to cholangiocarcinoma. The National Institute for Health Research Imperial Biomedical Research Centre has a £3.6 million gastroenterology and hepatology research theme (2012-17). This includes research on cholangiocarcinoma biomarkers and imaging.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/01/2015 12:35:01 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

178540

	registered interest
	date	09/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he expects to publish the results of the consultation for the NHS England Research and Development Strategy.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	223768
	answer	answer is ministerial correction date of answer 24/02/2015 answer text <p>The consultation for the NHS England Research and Development Strategy closed in December 2013. NHS England subsequently decided not to publish the results of the consultation at that time, but instead to use the findings to inform a new piece of work which would be developed with the Department which will describe NHS England’s role in promoting and taking account of research in the new healthcare system.</p><p> </p><p> </p><p> </p><p>NHS England is working with the Department to agree a revised approach.</p><p> </p><p> </p><p> </p><p>Delivery of NHS England’s research objective was discussed at the accountability meeting on 14 October 2014. The minutes of this meeting are available at:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377477/SofS_Accountability_Meeting_oct_2014.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377477/SofS_Accountability_Meeting_oct_2014.pdf</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 24/02/2015 16:49:23 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

226307

	registered interest
	date	10/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2015 to Question 223768, on which dates since 24 November 2014 he has discussed with NHS England its revised approach to promoting and taking account of research in the new healthcare system; and what the content of those discussions was.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	227007
	answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>Since 24 November 2014, there have been no discussions between my Rt. Hon. Friend the Secretary of State for Health and NHS England on its revised approach to promoting and taking account of research in the new healthcare system. However, discussions between senior officials in the Department and NHS England are ongoing.</p><p> </p><p> </p><p> </p><p>NHS England will be setting out high level plans through their Business Plan, which is due to be published on 27 March 2015. NHS England does not routinely consult on business plans and, as such, no formal consultation has been planned.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 227008 question first answered 17/03/2015 16:19:17 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith

226308

	registered interest
	date	10/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2015 to Question 223768, when NHS England plans to publish its revised approach to promoting and taking account of research in the new healthcare system; and what plans NHS England has to hold a formal consultation on that revised approach.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	227008
	answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>Since 24 November 2014, there have been no discussions between my Rt. Hon. Friend the Secretary of State for Health and NHS England on its revised approach to promoting and taking account of research in the new healthcare system. However, discussions between senior officials in the Department and NHS England are ongoing.</p><p> </p><p> </p><p> </p><p>NHS England will be setting out high level plans through their Business Plan, which is due to be published on 27 March 2015. NHS England does not routinely consult on business plans and, as such, no formal consultation has been planned.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 227007 question first answered 17/03/2015 16:19:16 answering member 4020 label Biography information for George Freeman
	tabling member	3960 label Biography information for Henry Smith